These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10212389)

  • 81. A novel type of retinoic acid receptor antagonist: synthesis and structure-activity relationships of heterocyclic ring-containing benzoic acid derivatives.
    Yoshimura H; Nagai M; Hibi S; Kikuchi K; Abe S; Hida T; Higashi S; Hishinuma I; Yamanaka T
    J Med Chem; 1995 Aug; 38(16):3163-73. PubMed ID: 7636879
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Triphenylsilyl as a protecting group in the synthesis of 1, 12-heterodisubstituted p-carboranes.
    Douglass AG; Pakhomov S; Reeves B; Janousek Z; Kaszynski P
    J Org Chem; 2000 Mar; 65(5):1434-41. PubMed ID: 10814106
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Synthesis of Closo-1,7-Carboranyl Alkyl Amines.
    Agarwal HK; Buszek B; Ricks KG; Tjarks W
    Tetrahedron Lett; 2011 Oct; 52(43):5664-5667. PubMed ID: 22003261
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Synthesis of Novel Carborane-Containing Derivatives of RGD Peptide.
    Vakhrushev AV; Gruzdev DA; Demin AM; Levit GL; Krasnov VP
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110700
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Synthesis of (S)-3-(1-hydroxy-p-carboran-12-yl)alanine, a novel hydrophobic tyrosine-mimetic for peptides.
    Ujváry I; Nachman RJ
    Peptides; 2002 Apr; 23(4):795-9. PubMed ID: 11897400
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Synthesis of an o-Carboranyl Derivative of 4-[5-(4-Methyl-1-piperazinyl)-2,5'-bi-1H-benzimidazol-2'-yl]phenol.
    Argentini M; Dos Santos DF; Weinreich R; Hansen HJ
    Inorg Chem; 1998 Nov; 37(23):6018-6022. PubMed ID: 11670736
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Modular triazine-based carborane-containing carboxylic acids - synthesis and characterisation of potential boron neutron capture therapy agents made of readily accessible building blocks.
    Kellert M; Worm DJ; Hoppenz P; Sárosi MB; Lönnecke P; Riedl B; Koebberling J; Beck-Sickinger AG; Hey-Hawkins E
    Dalton Trans; 2019 Aug; 48(29):10834-10844. PubMed ID: 31246208
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Novel thiazolidinedione derivatives with retinoid synergistic activity.
    Ebisawa M; Kawachi E; Fukasawa H; Hashimoto Y; Itai A; Shudo K; Kagechika H
    Biol Pharm Bull; 1998 May; 21(5):547-9. PubMed ID: 9635519
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Potent retinoid synergists with a diphenylamine skeleton.
    Ohta K; Tsuji M; Kawachi E; Fukasawa H; Hashimoto Y; Shudo K; Kagechika H
    Biol Pharm Bull; 1998 May; 21(5):544-6. PubMed ID: 9635518
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Synthesis, Characterization and In vitro Antitumour Activity of Novel Organotin Derivatives of 1,2- and 1,7-Dicarba-Closo-dodecaboranes.
    Gielen M; Kayser F; Zhidkova OB; Kampel VT; Bregadze VL; de Vos D; Biesemans M; Mahieu B; Willem R
    Met Based Drugs; 1995; 2(1):37-42. PubMed ID: 18472744
    [TBL] [Abstract][Full Text] [Related]  

  • 91. High affinity retinoic acid receptor antagonists: analogs of AGN 193109.
    Johnson AT; Wang L; Gillett SJ; Chandraratna RA
    Bioorg Med Chem Lett; 1999 Feb; 9(4):573-6. PubMed ID: 10098666
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Synthesis of 1-Amino-3-[2-(1,7-dicarba-closo-dodecaboran(12)-1-yl)ethyl]cyclobutanecarboxylic Acid: A Potential BNCT Agent.
    Srivastava RR; Singhaus RR; Kabalka GW
    J Org Chem; 1997 Jun; 62(13):4476-4478. PubMed ID: 11671777
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A short and efficient synthesis of 4-[2,2-dimethyl-4(tol-4-yl)benzochrom-3-en-7-yl]benzoic acid - a potent retinoic acid receptor antagonist.
    Vuligonda V; Chandraratna RA
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2289-90. PubMed ID: 10476855
    [TBL] [Abstract][Full Text] [Related]  

  • 94. C-Hydroxydicarba-closo-dodecaboranes.
    Zharov I; Saxena A; Michl J; Miller RD
    Inorg Chem; 1997 Dec; 36(26):6033-6038. PubMed ID: 11670236
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Design and synthesis of boron containing potential pan-RAR inverse agonists.
    Das BC; Tang XY; Evans T
    Tetrahedron Lett; 2012 Mar; 53(11):1316-1318. PubMed ID: 23180890
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Synthesis and biological evaluation of a new series of ortho-carboranyl biphenyloxime derivatives.
    Jin G; Xiao F; Liu R
    Chem Cent J; 2018 Jun; 12(1):76. PubMed ID: 29959549
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The Boron Advantage: The Evolution and Diversification of Boron's Applications in Medicinal Chemistry.
    Messner K; Vuong B; Tranmer GK
    Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337063
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Metal-catalyzed B-H acylmethylation of pyridylcarboranes: access to carborane-fused indoliziniums and quinoliziniums.
    Cao HJ; Wei X; Sun F; Zhang X; Lu C; Yan H
    Chem Sci; 2021 Dec; 12(47):15563-15571. PubMed ID: 35003585
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Carborane-based design of a potent vitamin D receptor agonist.
    Otero R; Seoane S; Sigüeiro R; Belorusova AY; Maestro MA; Pérez-Fernández R; Rochel N; Mouriño A
    Chem Sci; 2016 Feb; 7(2):1033-1037. PubMed ID: 28808527
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Docking simulations suggest that all-trans retinoic acid could bind to retinoid X receptors.
    Tsuji M; Shudo K; Kagechika H
    J Comput Aided Mol Des; 2015 Oct; 29(10):975-88. PubMed ID: 26384496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.